Home

Spécialiste Coût contribution efficacy data Les agriculteurs Des sports Nomination

Efficacy and Clinical Trial Data | MAYZENT | HCP
Efficacy and Clinical Trial Data | MAYZENT | HCP

Avastin® (bevacizumab) Clinical Trials | MCRC Treatment
Avastin® (bevacizumab) Clinical Trials | MCRC Treatment

XOSPATA® (gilteritinib) ADMIRAL Trial Efficacy Data
XOSPATA® (gilteritinib) ADMIRAL Trial Efficacy Data

Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of  concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised  controlled trial - The Lancet
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial - The Lancet

Phase 3 Data Demonstrate RSVpreF Vaccine Efficacy in Older Adults with RSV
Phase 3 Data Demonstrate RSVpreF Vaccine Efficacy in Older Adults with RSV

Clinical Data Efficacy | QINLOCK® (ripretinib)
Clinical Data Efficacy | QINLOCK® (ripretinib)

IMpower150, IMpower110, & OAK Efficacy Results & Clinical Data | TECENTRIQ®  (atezolizumab)
IMpower150, IMpower110, & OAK Efficacy Results & Clinical Data | TECENTRIQ® (atezolizumab)

Clinical Studies in Treatment-Naïve Adults | BIKTARVY® HCP
Clinical Studies in Treatment-Naïve Adults | BIKTARVY® HCP

COVID-19 vaccine efficacy calculated from data | Towards Data Science
COVID-19 vaccine efficacy calculated from data | Towards Data Science

New data shed light on efficacy of J&J's single-dose Covid vaccine
New data shed light on efficacy of J&J's single-dose Covid vaccine

Efficacy Data | Palynziq HCP
Efficacy Data | Palynziq HCP

Clinical Efficacy Data | MVASI® (bevacizumab)
Clinical Efficacy Data | MVASI® (bevacizumab)

Covid: What do we know about China's coronavirus vaccines? - BBC News
Covid: What do we know about China's coronavirus vaccines? - BBC News

Indian state rejects Bharat Biotech vaccine approved without efficacy data  | Reuters
Indian state rejects Bharat Biotech vaccine approved without efficacy data | Reuters

Pivotal Efficacy Data | DSUVIA® (sufentanil) sublingual tablet, 30 mcg | HCP
Pivotal Efficacy Data | DSUVIA® (sufentanil) sublingual tablet, 30 mcg | HCP

Clinical Studies in Treatment-Naïve Adults | BIKTARVY® HCP
Clinical Studies in Treatment-Naïve Adults | BIKTARVY® HCP

Mount Sinai Team Offers Additional Data on Efficacy of Blood Thinners for  COVID-19 and Insight on Best Potential Regimens | Mount Sinai - New York
Mount Sinai Team Offers Additional Data on Efficacy of Blood Thinners for COVID-19 and Insight on Best Potential Regimens | Mount Sinai - New York

VOYAGE 1: Moderate to Severe PsO | TREMFYA® (guselkumab) HCP
VOYAGE 1: Moderate to Severe PsO | TREMFYA® (guselkumab) HCP

Trial Design & Efficacy | REVLIMID® (lenalidomide) + dexamethasone
Trial Design & Efficacy | REVLIMID® (lenalidomide) + dexamethasone

REXULTI® (brexpiprazole) | Efficacy
REXULTI® (brexpiprazole) | Efficacy

COVID-19: Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
COVID-19: Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273  COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care  Personnel, First Responders, and Other Essential and Frontline Workers —  Eight U.S. Locations, December
Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers — Eight U.S. Locations, December

Know Your Data: Vaccines – What's the Difference Between Effectiveness and  Efficacy? | Qlik Blog
Know Your Data: Vaccines – What's the Difference Between Effectiveness and Efficacy? | Qlik Blog

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months  | NEJM
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months | NEJM

A comprehensive analysis of the efficacy and safety of COVID-19 vaccines -  ScienceDirect
A comprehensive analysis of the efficacy and safety of COVID-19 vaccines - ScienceDirect

Pfizer Inc. on Twitter: "BREAKING: Along with @BioNTech_Group, we shared  updated data from a Phase 2/3 study of our #COVID19 vaccine in children 6  mos through 4 yrs. Learn more about these
Pfizer Inc. on Twitter: "BREAKING: Along with @BioNTech_Group, we shared updated data from a Phase 2/3 study of our #COVID19 vaccine in children 6 mos through 4 yrs. Learn more about these